|
|
|
Insider
Information: |
Balo Andrew K |
Relationship: |
EVP Regulatory Strateg... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
50,908 |
|
Indirect Shares
|
30,212 |
|
|
Direct
Value |
$6,687,275 |
|
|
Indirect Value
|
$3,968,648 |
|
|
Total
Shares |
81,120 |
|
|
Total
Value |
$10,655,923 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
90.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DXCM |
DexCom Inc |
VP of Clinical and RegulatoryO |
|
2005-04-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,500 |
|
- |
|
DXCM |
DexCom Inc |
VP of Clinical & Regulatory |
|
2006-05-02 |
4 |
S |
$24.00 |
$2,400,000 |
D/D |
(100,000) |
876 |
|
- |
|
DXCM |
DexCom Inc |
VP of Clinical & Regulatory |
|
2006-05-02 |
4 |
OE |
$0.30 |
$21,450 |
D/D |
47,500 |
100,876 |
|
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2008-11-21 |
4 |
B |
$1.51 |
$10,720 |
I/I |
7,000 |
7,000 |
1.99 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2011-03-08 |
4 |
A |
$0.00 |
$44 |
D/D |
43,750 |
49,510 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-03-08 |
4 |
A |
$0.00 |
$54 |
D/D |
53,750 |
103,622 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-03-08 |
4 |
D |
$10.26 |
$57,262 |
D/D |
(5,582) |
98,040 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-05-18 |
4 |
S |
$10.46 |
$148,488 |
D/D |
(14,198) |
112,308 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-05-18 |
4 |
OE |
$0.50 |
$14,233 |
D/D |
28,466 |
126,506 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-09-10 |
4 |
D |
$13.68 |
$37,392 |
D/D |
(2,734) |
109,733 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-12-13 |
4 |
S |
$13.98 |
$80,528 |
D/D |
(5,760) |
103,973 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2012-12-13 |
4 |
S |
$13.96 |
$97,697 |
I/I |
(7,000) |
0 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-03-11 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
154,218 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-03-13 |
4 |
S |
$16.53 |
$254,814 |
D/D |
(15,416) |
144,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-03-13 |
4 |
OE |
$0.50 |
$7,708 |
D/D |
15,416 |
159,987 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-03-13 |
4 |
D |
$15.69 |
$151,361 |
D/D |
(9,647) |
144,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-05-13 |
4 |
OE |
$2.40 |
$108,000 |
D/D |
45,000 |
189,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-05-13 |
4 |
S |
$19.40 |
$873,000 |
D/D |
(45,000) |
144,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-06-13 |
4 |
S |
$21.90 |
$219,015 |
D/D |
(10,000) |
144,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-06-13 |
4 |
OE |
$2.40 |
$24,000 |
D/D |
10,000 |
154,571 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-09-09 |
4 |
D |
$26.89 |
$166,714 |
D/D |
(6,200) |
138,565 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-11-11 |
4 |
OE |
$2.40 |
$37,051 |
D/D |
15,438 |
154,003 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-11-11 |
4 |
S |
$33.17 |
$512,034 |
D/D |
(15,438) |
138,565 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-11-12 |
4 |
S |
$33.15 |
$887,890 |
D/D |
(26,784) |
138,565 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2013-11-12 |
4 |
OE |
$2.40 |
$64,282 |
D/D |
26,784 |
165,349 |
0 |
- |
|
200 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|